Reumatoloxía

2022

1. Injection site reaction with subcutaneous methotrexate

   Dermatologic Therapy

2. More, none, less therapeutic effect? Should we start talking about a 'lessebo' effect?

   Rheumatology (United Kingdom)

3. Reducing bureaucracy in clinical trials, now is the time!

   RMD Open

4. Response to: 'Use of tanezumab for patients with hip and knee osteoarthritis with reference to a randomised clinical trial by Berenbaum and colleagues' by Riddle and Perera

   Annals of the Rheumatic Diseases

5. SARS-CoV-2 infection after vaccination in patients with inflammatory rheumatic and musculoskeletal diseases

   Annals of the rheumatic diseases

6. The role of PET/CT in the evaluation of patients with large-vessel vasculitis: Useful for diagnosis but with potential limitations for follow-up

   Rheumatology (United Kingdom)